T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
The Mosaic Company
MOS
$7.18B
| $106M | 0.02% |
2,327,823
+339,110
| +17% | +$15M |
|
602
Encompass Health
EHC
$12.3B
| $106M | 0.02% |
3,466,362
+13,952
| +0.4% | +$435K |
|
603
Ryanair
RYAAY
$30.8B
| $106M | 0.02% |
3,617,642
-491,971
| -12% | -$12.3M |
|
604
Red Robin
RRGB
$151M
| $106M | 0.02% |
1,373,837
-118,840
| -8% | -$7.55M |
|
605
Coca-Cola Europacific Partners
CCEP
$47.3B
| $106M | 0.02% |
2,390,717
+2,002,370
| +516% | +$86.4M |
|
|
SLXP
606
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $105M | 0.02% |
914,873
+680,400
| +290% | +$82.4M |
|
607
Air Products & Chemicals
APD
$67.7B
| $105M | 0.02% |
785,359
+15,152
| +2% | +$1.92M |
|
|
ININ
608
DELISTED
Interactive Intelligence Group, inc.
ININ
| $105M | 0.02% |
2,185,164
+111,110
| +5% | +$4.96M |
|
|
TMUSP
609
DELISTED
T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A
TMUSP
| $104M | 0.02% |
+2,000,000
| New | +$104M |
|
610
Steris
STE
$23.1B
| $104M | 0.02% |
1,608,071
-21,560
| -1% | -$1.33M |
|
611
Amphenol
APH
$210B
| $104M | 0.02% |
7,729,872
+4,643,912
| +150% | +$59.4M |
|
|
HMSY
612
DELISTED
HMS Holdings Corp.
HMSY
| $104M | 0.02% |
4,903,069
+674,380
| +16% | +$14.1M |
|
613
West Pharmaceutical
WST
$24.8B
| $103M | 0.02% |
1,930,669
-38,722
| -2% | -$1.94M |
|
|
HAPN
614
Happen Inc
HAPN
$2.25B
| $103M | 0.02% |
+832,892
| New | +$105M |
|
615
Tenet Healthcare
THC
$21.5B
| $101M | 0.02% |
1,994,660
+29,700
| +2% | +$1.55M |
|
|
JCP
616
DELISTED
J.C. Penney Company, Inc.
JCP
| $101M | 0.02% |
15,583,207
+301,281
| +2% | +$2.21M |
|
|
ALOG
617
DELISTED
Analogic Corp
ALOG
| $101M | 0.02% |
1,189,074
+11,322
| +1% | +$849K |
|
618
St. Joe Company
JOE
$3.87B
| $101M | 0.02% |
5,467,675
+925,910
| +20% | +$17.5M |
|
619
Helios Technologies
HLIO
$2.67B
| $100M | 0.02% |
2,545,049
-27,991
| -1% | -$1.09M |
|
|
KNGT
620
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
| $99.9M | 0.02% |
2,967,267
-339,520
| -10% | -$11.4M |
|
|
SCU
621
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $99.7M | 0.02% |
853,870
+77,851
| +10% | +$8.81M |
|
622
W.W. Grainger
GWW
$61.5B
| $98.7M | 0.02% |
387,102
-1,189,017
| -75% | -$293M |
|
|
TCO
623
DELISTED
Taubman Centers Inc.
TCO
| $98.5M | 0.02% |
1,289,497
+4,675
| +0.4% | +$357K |
|
|
ECOL
624
DELISTED
US Ecology, Inc.
ECOL
| $98.4M | 0.02% |
2,453,796
-183,166
| -7% | -$7.83M |
|
625
Marathon Petroleum
MPC
$97.8B
| $98.4M | 0.02% |
2,180,318
+528,900
| +32% | +$23.3M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.